Personalized Recommendation System for Sport Activities
NCT ID: NCT06200350
Last Updated: 2025-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
47 participants
INTERVENTIONAL
2024-04-15
2025-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Q1: Improving participant performance is achieved by using personalized sports activity recommendation using an algorithm and tracking compliance using a decentralized application (dApp)? Q2: Are participants satisfied with the performance and simplicity of the dApp used?
Participants will be asked to do specific activities recommended by the developed recommender system. The activities to be carried out will be conditioned by the profile obtained from each participant at the beginning of the intervention. They will consist of reinforcement activities for the dimensions with the lowest scores.
Researchers will compare a experimental group and a control group to see if the dimensions assessed at the beginning of the intervention were improved.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Clinical Referral to Activity Study
NCT04743856
Improving Health Status in COVID-19 Long-Hauler
NCT06679218
A Smartphone-based Intervention to Promote an Active Lifestyle in Low Educated Working Young Adults
NCT02948803
Program to Promote Physical Activity and Healthy Habits in Adolescents
NCT03974607
Random Assignment of Intervention Messages for Developing Personalized Decision Rules to Promote Physical Activity
NCT03907683
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
This group will carry out the tailored training proposed by de recommender system, and followed and encouraged by the blockchain dApp.
Experimental group
Tailored training based on the profile of each participant.
Control group
This group will continue with the traditional training planned.
Control group
They will continue with the traditional training.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental group
Tailored training based on the profile of each participant.
Control group
They will continue with the traditional training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 14 and 18 years old.
* Without any injury.
* The ones who can attend the assessing sessions and fill in the informed consent form.
Exclusion Criteria
* Injured.
* Missing one of the assessing sessions.
* Not performing the proposed training twice, or not registering two or more training sessions.
14 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Vigo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juan López Barreiro
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Vigo
Pontevedra, Pontevedra, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ED481A-2021/350
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
09-181223
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.